These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 10934222)

  • 1. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.
    Bottino C; Falco M; Parolini S; Marcenaro E; Augugliaro R; Sivori S; Landi E; Biassoni R; Notarangelo LD; Moretta L; Moretta A
    J Exp Med; 2001 Aug; 194(3):235-46. PubMed ID: 11489943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
    Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
    Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
    Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
    Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.
    Nakajima H; Cella M; Bouchon A; Grierson HL; Lewis J; Duckett CS; Cohen JI; Colonna M
    Eur J Immunol; 2000 Nov; 30(11):3309-18. PubMed ID: 11093147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
    Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
    PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
    Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
    Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
    Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
    J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.
    Tangye SG; Lazetic S; Woollatt E; Sutherland GR; Lanier LL; Phillips JH
    J Immunol; 1999 Jun; 162(12):6981-5. PubMed ID: 10358138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
    Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
    Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2B4-mediated activation of human natural killer cells.
    Tangye SG; Cherwinski H; Lanier LL; Phillips JH
    Mol Immunol; 2000 Jun; 37(9):493-501. PubMed ID: 11163399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.
    Aoukaty A; Tan R
    J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.